Related references
Note: Only part of the references are listed.Oral Azole Antifungal Medications and Risk of Acute Liver Injury, Overall and by Chronic Liver Disease Status
Vincent Lo Re et al.
AMERICAN JOURNAL OF MEDICINE (2016)
Activation of apoptosis signalling pathways by reactive oxygen species
Maureen Redza-Dutordoir et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2016)
Superior Serum Concentrations with Posaconazole Delayed-Release Tablets Compared to Suspension Formulation in Hematological Malignancies
Aaron Cumpston et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Valproic Acid-Induced Hepatotoxicity in Alpers Syndrome Is Associated With Mitochondrial Permeability Transition Pore Opening-Dependent Apoptotic Sensitivity in an Induced Pluripotent Stem Cell Model
Shengbiao Li et al.
HEPATOLOGY (2015)
Impaired mitochondrial function in HepG2 cells treated with hydroxy-cobalamin[c-lactam]: A cell model for idiosyncratic toxicity
Patrizia Haegler et al.
TOXICOLOGY (2015)
The utility of HepG2 cells to identify direct mitochondrial dysfunction in the absence of cell death
Laleh Kamalian et al.
TOXICOLOGY IN VITRO (2015)
Risk of oral antifungal agent-induced liver injury in Taiwanese
Wei-Yu Kao et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2014)
Novel antifungal agents: a patent review (2011-present)
Maria Victoria Castelli et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2014)
Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology
H. Ruth Ashbee et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Liver Injury Associated With Ketoconazole: Review of the Published Evidence
H. Karl Greenblatt et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2014)
Oxidative stress: the mitochondria-dependent and mitochondria-independent pathways of apoptosis
Krishnendu Sinha et al.
ARCHIVES OF TOXICOLOGY (2013)
Decreased Mitochondrial DNA Content in Association with Exposure to Polycyclic Aromatic Hydrocarbons in House Dust during Wintertime: From a Population Enquiry to Cell Culture
Nicky Pieters et al.
PLOS ONE (2013)
Mechanisms of Hepatocellular Toxicity Associated with Dronedarone-A Comparison to Amiodarone
Andrea Felser et al.
TOXICOLOGICAL SCIENCES (2013)
The biology and chemistry of antifungal agents: A review
Muthu K. Kathiravan et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2012)
Characterization of primary human hepatocytes, HepG2 cells, and HepaRG cells at the mRNA level and CYP activity in response to inducers and their predictivity for the detection of human hepatotoxins
H. H. J. Gerets et al.
CELL BIOLOGY AND TOXICOLOGY (2012)
Advances in systemic antifungal therapy
David A. Stevens
CLINICS IN DERMATOLOGY (2012)
Lack of hepato- and nephrotoxicity induced by antifungal drug voriconazole in laboratory rats
Nhareet Somchit et al.
DRUG AND CHEMICAL TOXICOLOGY (2012)
Triazole Antifungal Agents in Invasive Fungal Infections A Comparative Review
Cornelia Lass-Floerl
DRUGS (2011)
Current Concepts in Antifungal Pharmacology
Russell E. Lewis
MAYO CLINIC PROCEEDINGS (2011)
Flavin monooxygenases, FMO1 and FMO3, not cytochrome P450 isoenzymes, contribute to metabolism of anti-tumour triazoloacridinone, C-1305, in liver microsomes and HepG2 cells
Barbara Fedejko-Kap et al.
XENOBIOTICA (2011)
Polymerase γ Gene POLG Determines the Risk of Sodium Valproate-Induced Liver Toxicity
Joanna D. Stewart et al.
HEPATOLOGY (2010)
Toxicological and pathophysiological roles of reactive oxygen and nitrogen species
Ruth A. Roberts et al.
TOXICOLOGY (2010)
Flavin-containing monooxygenase-3: Induction by 3-methylcholanthrene and complex regulation by xenobiotic chemicals in hepatoma cells and mouse liver
Trine Celius et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2010)
Aryl Hydrocarbon Receptor-Dependent Induction of Flavin-Containing Monooxygenase mRNAs in Mouse Liver
Trine Celius et al.
DRUG METABOLISM AND DISPOSITION (2008)
The Nrf2-Keapl defence pathway: Role in protection against drug-induced toxicity
Ian M. Copple et al.
TOXICOLOGY (2008)
Lack of Cross-Hepatotoxicity between Voriconazole and Posaconazole
Stephen D. Lawn et al.
CLINICAL INFECTIOUS DISEASES (2007)
Lack of cross-hepatotoxicity between voriconazole and posaconazole
Hong Foo et al.
CLINICAL INFECTIOUS DISEASES (2007)
Hepatocellular toxicity and pharmacological effect of amiodarone and amiodarone derivatives
Katri Maria Waldhauser et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Mechanisms of benzarone and benzbromarone-induced hepatic toxicity
P Kaufmann et al.
HEPATOLOGY (2005)
Mitochondria, oxidants, and aging
RS Balaban et al.
CELL (2005)
Identification of the cytochrome P450 enzymes involved in the N-oxidation of voriconazole
R Hyland et al.
DRUG METABOLISM AND DISPOSITION (2003)
Hepatotoxicity of ketoconazole in Sprague-Dawley rats: glutathione depletion, flavincontaining monooxygenases-mediated bioactivation and hepatic covalent binding
RJ Rodriguez et al.
XENOBIOTICA (2003)
Chemical-induced apoptosis: Formation of the Apaf-1 apoptosome
K Cain
DRUG METABOLISM REVIEWS (2003)
Poly(ADP-ribose) polymerase-1 cleavage during apoptosis: An update
C Soldani et al.
APOPTOSIS (2002)
Mitochondrial diseases represent a risk factor for valproate-induced fulminant liver failure
S Krähenbühl et al.
LIVER (2000)